Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Alibaba Health Information Technology

DB:TWY
Snowflake Description

High growth potential with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TWY
DB
HK$156B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People’s Republic of China. The last earnings update was 104 days ago. More info.


Add to Portfolio Compare Print
  • Alibaba Health Information Technology has significant price volatility in the past 3 months.
TWY Share Price and Events
7 Day Returns
5.9%
DB:TWY
9.5%
DE Healthcare Services
9.9%
DE Market
1 Year Returns
54.5%
DB:TWY
0.2%
DE Healthcare Services
-17.5%
DE Market
TWY Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Alibaba Health Information Technology (TWY) 5.9% -12.3% 44.4% 54.5% 236.9% 117.9%
DE Healthcare Services 9.5% -6.5% -16.6% 0.2% 27.1% 88.9%
DE Market 9.9% -16.6% -24.8% -17.5% -24.5% -28.1%
1 Year Return vs Industry and Market
  • TWY outperformed the Healthcare Services industry which returned 0.2% over the past year.
  • TWY outperformed the Market in Germany which returned -17.5% over the past year.
Price Volatility
TWY
Industry
5yr Volatility vs Market
Related Companies

TWY Value

 Is Alibaba Health Information Technology undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Alibaba Health Information Technology to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Alibaba Health Information Technology.

DB:TWY Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 5.6%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:TWY
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 6.1%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.97
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.971 (1 + (1- 25%) (0.76%))
0.985
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.98
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.985 * 6.07%)
5.59%

Discounted Cash Flow Calculation for DB:TWY using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Alibaba Health Information Technology is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:TWY DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CNY, Millions) Source Present Value
Discounted (@ 5.59%)
2020 226.00 Analyst x2 214.04
2021 794.50 Analyst x2 712.66
2022 2,156.50 Analyst x2 1,832.02
2023 2,928.70 Est @ 35.81% 2,356.39
2024 3,659.36 Est @ 24.95% 2,788.51
2025 4,294.15 Est @ 17.35% 3,099.11
2026 4,810.56 Est @ 12.03% 3,288.13
2027 5,209.89 Est @ 8.3% 3,372.68
2028 5,506.53 Est @ 5.69% 3,376.12
2029 5,719.55 Est @ 3.87% 3,321.21
Present value of next 10 years cash flows CN¥24,360.00
DB:TWY DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= CN¥5,719.55 × (1 + -0.39%) ÷ (5.59% – -0.39%)
CN¥95,334.44
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CN¥95,334.44 ÷ (1 + 5.59%)10
CN¥55,358.43
DB:TWY Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CN¥24,360.00 + CN¥55,358.43
CN¥79,718.43
Equity Value per Share
(CNY)
= Total value / Shares Outstanding
= CN¥79,718.43 / 12,062.52
CN¥6.61
DB:TWY Discount to Share Price
Calculation Result
Exchange Rate CNY/HKD
(Reporting currency to currency of SEHK:241)
1.092
Value per Share
(HKD)
= Value per Share in CNY x Exchange Rate (CNY/HKD)
= CN¥6.61 x 1.092
HK$7.22
Non-primary Listing Adjustment Factor 1 share in DB:TWY represents 0.12037x of SEHK:241
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.12037x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (HKD) x Listing Adjustment Factor
= HK$ 7.22 x 0.12037
€0.87
Value per share (EUR) From above. €0.87
Current discount Discount to share price of €1.56
= -1 x (€1.56 - €0.87) / €0.87
-79.5%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Alibaba Health Information Technology is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Alibaba Health Information Technology's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Alibaba Health Information Technology's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:TWY PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CNY CN¥0.00
SEHK:241 Share Price ** SEHK (2020-03-31) in HKD HK$12.96
SEHK:241 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.915 CN¥11.86
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.39x
Germany Market PE Ratio Median Figure of 399 Publicly-Listed Companies 16.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Alibaba Health Information Technology.

DB:TWY PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:241 Share Price ÷ EPS (both in CNY)

= 11.86 ÷ 0.00

133312.81x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alibaba Health Information Technology is overvalued based on earnings compared to the DE Healthcare Services industry average.
  • Alibaba Health Information Technology is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does Alibaba Health Information Technology's expected growth come at a high price?
Raw Data
DB:TWY PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 133312.81x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
129.2%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.3x
Germany Market PEG Ratio Median Figure of 255 Publicly-Listed Companies 1.18x

*Line of best fit is calculated by linear regression .

DB:TWY PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 133312.81x ÷ 129.2%

1031.73x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alibaba Health Information Technology is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Alibaba Health Information Technology's assets?
Raw Data
DB:TWY PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CNY CN¥0.42
SEHK:241 Share Price * SEHK (2020-03-31) in HKD HK$12.96
SEHK:241 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.915 CN¥11.86
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.94x
Germany Market PB Ratio Median Figure of 571 Publicly-Listed Companies 1.43x
DB:TWY PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:241 Share Price ÷ Book Value per Share (both in CNY)

= 11.86 ÷ 0.42

27.97x

* Primary Listing of Alibaba Health Information Technology.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alibaba Health Information Technology is overvalued based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess Alibaba Health Information Technology's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Alibaba Health Information Technology has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

TWY Future Performance

 How is Alibaba Health Information Technology expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
129.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Alibaba Health Information Technology expected to grow at an attractive rate?
  • Alibaba Health Information Technology's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • Alibaba Health Information Technology's earnings growth is expected to exceed the Germany market average.
  • Alibaba Health Information Technology's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:TWY Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:TWY Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 129.2%
DB:TWY Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 56.5%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.3%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.4%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:TWY Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in CNY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:TWY Future Estimates Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-03-31 26,677 2,172 974 5
2021-03-31 16,292 810 399 6
2020-03-31
2020-03-31 9,153 -140 -14 6
DB:TWY Past Financials Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income *
2019-09-30 7,334 570 1
2019-06-30 6,215 483 -40
2019-03-31 5,096 396 -82
2018-12-31 4,264 373 -91
2018-09-30 3,432 349 -100
2018-06-30 2,937 139 -104
2018-03-31 2,443 -70 -107
2017-12-31 1,876 -157 -152
2017-09-30 1,310 -244 -196
2017-06-30 892 -235 -202
2017-03-31 475 -226 -208
2016-12-31 285 -186 -201

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Alibaba Health Information Technology's earnings are expected to grow significantly at over 20% yearly.
  • Alibaba Health Information Technology's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:TWY Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Alibaba Health Information Technology Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:TWY Future Estimates Data
Date (Data in CNY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-03-31 0.11 0.23 0.02 4.00
2021-03-31 0.03 0.09 0.00 5.00
2020-03-31
2020-03-31 0.00 0.01 -0.01 5.00
DB:TWY Past Financials Data
Date (Data in CNY Millions) EPS *
2019-09-30 0.00
2019-06-30 0.00
2019-03-31 -0.01
2018-12-31 -0.01
2018-09-30 -0.01
2018-06-30 -0.01
2018-03-31 -0.01
2017-12-31 -0.02
2017-09-30 -0.02
2017-06-30 -0.02
2017-03-31 -0.03
2016-12-31 -0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Alibaba Health Information Technology is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Alibaba Health Information Technology's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Alibaba Health Information Technology has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

TWY Past Performance

  How has Alibaba Health Information Technology performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Alibaba Health Information Technology's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Alibaba Health Information Technology's year on year earnings growth rate has been positive over the past 5 years.
  • Alibaba Health Information Technology has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • Alibaba Health Information Technology has become profitable in the last year making it difficult to compare the DE Healthcare Services industry average.
Earnings and Revenue History
Alibaba Health Information Technology's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Alibaba Health Information Technology Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:TWY Past Revenue, Cash Flow and Net Income Data
Date (Data in CNY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 7,334.00 1.05 1,624.46 250.48
2019-06-30 6,214.94 -40.45 1,416.22 234.75
2019-03-31 5,095.87 -81.95 1,207.98 219.02
2018-12-31 4,263.73 -91.06 1,033.66 193.77
2018-09-30 3,431.60 -100.17 859.35 168.52
2018-06-30 2,937.11 -103.57 760.23 147.37
2018-03-31 2,442.62 -106.97 661.11 126.22
2017-12-31 1,876.20 -151.56 562.98 122.87
2017-09-30 1,309.78 -196.14 464.85 119.52
2017-06-30 892.43 -201.88 370.50 114.05
2017-03-31 475.08 -207.63 276.15 108.58
2016-12-31 284.75 -200.58 233.32 99.43
2016-09-30 94.43 -193.53 190.50 90.27
2016-06-30 75.51 -192.57 181.54 83.21
2016-03-31 56.60 -191.61 172.58 76.15
2015-12-31 44.31 -173.16 175.14 68.17
2015-09-30 31.64 -154.02 177.20 59.92
2015-06-30 30.88 -117.96 145.33 47.16
2015-03-31 29.74 -81.22 112.97 34.13
2014-12-31 30.80 -60.49 84.84 23.81
2014-09-30 31.50 -39.31 34.96 23.49
2014-06-30 27.01 -35.68 34.51 18.69
2014-03-31 22.03 -31.42 33.50 13.53
2013-12-31 16.44 -34.79 34.29 6.59
2013-09-30 11.54 -39.39 36.34
2013-06-30 12.08 -36.13 34.42

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Alibaba Health Information Technology has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Alibaba Health Information Technology used its assets less efficiently than the DE Healthcare Services industry average last year based on Return on Assets.
  • It is difficult to establish if Alibaba Health Information Technology improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Alibaba Health Information Technology's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Alibaba Health Information Technology has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

TWY Health

 How is Alibaba Health Information Technology's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Alibaba Health Information Technology's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Alibaba Health Information Technology is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Alibaba Health Information Technology's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Alibaba Health Information Technology's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 5.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Alibaba Health Information Technology Company Filings, last reported 6 months ago.

DB:TWY Past Debt and Equity Data
Date (Data in CNY Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 4,956.62 1,000.00 3,769.13
2019-06-30 4,956.62 1,000.00 3,769.13
2019-03-31 2,736.83 1,700.00 2,017.08
2018-12-31 2,736.83 1,700.00 2,017.08
2018-09-30 2,634.94 1,249.38 2,290.28
2018-06-30 2,634.94 1,249.38 2,290.28
2018-03-31 2,523.06 0.00 1,397.20
2017-12-31 2,523.06 0.00 1,397.20
2017-09-30 1,063.17 200.00 204.15
2017-06-30 1,063.17 200.00 204.15
2017-03-31 1,119.66 200.00 589.48
2016-12-31 1,119.66 200.00 589.48
2016-09-30 1,137.57 100.61 565.49
2016-06-30 1,137.57 100.61 565.49
2016-03-31 1,155.27 0.00 1,031.78
2015-12-31 1,155.27 0.00 1,031.78
2015-09-30 1,194.99 0.00 1,159.95
2015-06-30 1,165.25 0.00 1,131.08
2015-03-31 1,266.89 0.00 1,229.25
2014-12-31 1,266.61 0.00 1,228.97
2014-09-30 1,300.90 0.00 1,219.65
2014-06-30 1,320.40 0.00 1,237.93
2014-03-31 282.13 0.00 180.73
2013-12-31 274.86 0.00 176.07
2013-09-30 217.66 22.86 102.21
2013-06-30 218.38 22.93 102.55
  • Alibaba Health Information Technology's level of debt (20.2%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Alibaba Health Information Technology's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (57%, greater than 20% of total debt).
  • Unable to confirm if the interest payments on Alibaba Health Information Technology's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess Alibaba Health Information Technology's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Alibaba Health Information Technology has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

TWY Dividends

 What is Alibaba Health Information Technology's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Alibaba Health Information Technology dividends. Estimated to be 0% next year.
If you bought €2,000 of Alibaba Health Information Technology shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Alibaba Health Information Technology's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Alibaba Health Information Technology's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:TWY Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.8%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:TWY Future Dividends Estimate Data
Date (Data in CN¥) Dividend per Share (annual) Avg. No. Analysts
2022-03-31 0.00 3.00
2021-03-31 0.00 3.00
2020-03-31
2020-03-31 0.00 3.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Alibaba Health Information Technology has not reported any payouts.
  • Unable to verify if Alibaba Health Information Technology's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Alibaba Health Information Technology's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Alibaba Health Information Technology has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Alibaba Health Information Technology's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Alibaba Health Information Technology's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Alibaba Health Information Technology afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Alibaba Health Information Technology has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

TWY Management

 What is the CEO of Alibaba Health Information Technology's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Shunyan Zhu
AGE 48
TENURE AS CEO 0 years
CEO Bio

Mr. Shunyan Zhu serves as Chairman of the Board and Chief Executive Officer and Executive Director at Alibaba Health Information Technology Limited since March 16, 2020. He is the President of the Innovation Initiatives Segment of the ultimatecontrolling shareholder of the Company, Alibaba Group Holding Limited (whichAmerican depositary shares, each representing eight ordinary shares, are listed on theNew York Stock Exchange (Stock Symbol: BABA), and which ordinary shares are listedon the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 9988))and its subsidiaries (collectively, ‘‘Alibaba Group’’). Prior to joining Alibaba Group, Mr.Zhu founded Wuhan Xuncai Technology Co., Ltd.* (????????) in 2003. Hejoined the founding team of UC Browser in 2007 as Senior Vice President, and was–1– responsible for the marketing and commercialization of UC Browser. The business of UCBrowser was acquired by Alibaba Group in June 2014. In June 2016, Mr. Zhu became thePresident of Alimama Business Group, a leading big data marketing platform in thePeople’s Republic of China operated by Alibaba Group. He has been (i) the President ofUC Browser since December 2017, (ii) the President of New Media Businesses of AlibabaDigital Media & Entertainment Business Group and in charge of the businessdepartments of UC Browser, Alibaba Music and Innovation Business since December2018, and (iii) the President of the Innovation Initiatives Segment since June 2019. Mr.Zhu obtained a Bachelor of Science Degree in Mathematics in 1993 from YanshanUniversity in the PRC. He obtained a Master Degree in Computing Software in 1996from Huazhong University of Science and Technology in the PRC.

CEO Compensation
  • Insufficient data for Shunyan to compare compensation growth.
  • Insufficient data for Shunyan to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team

Gary Wang

TITLE
CFO & Executive Director
COMPENSATION
CN¥5M
AGE
42
TENURE
2.4 yrs

Shunyan Zhu

TITLE
Chairman of the Board & CEO
AGE
48

Nicole Lew

TITLE
General Counsel & Company Secretary

Chun Chung Kwong

TITLE
Financial Controller
Board of Directors Tenure

Average tenure and age of the Alibaba Health Information Technology board of directors in years:

4.8
Average Tenure
45.5
Average Age
  • The tenure for the Alibaba Health Information Technology board of directors is about average.
Board of Directors

Shunyan Zhu

TITLE
Chairman of the Board & CEO
AGE
48

Samuel Wong

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥542K
AGE
66
TENURE
5.8 yrs

Gary Wang

TITLE
CFO & Executive Director
COMPENSATION
CN¥5M
AGE
42
TENURE
1.7 yrs

Vanessa Huang

TITLE
Independent Non-Executive Director
AGE
46
TENURE
0.7 yrs

Tong Luo

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥293K
AGE
52
TENURE
5.8 yrs

Eddie Wu

TITLE
Non-Executive Director
AGE
44
TENURE
4.8 yrs

Lei Wang

TITLE
Non-Executive Director
COMPENSATION
CN¥8M
AGE
39
TENURE
4.8 yrs

Hong Xu

TITLE
Non-Executive Director
AGE
45
TENURE
0.7 yrs

Li Ma

TITLE
Director of Alibaba Health Technology(Beijing) Company Limited

Larry Meng

TITLE
Director of Alibaba Health Technology(Beijing) Company Limited
Who owns this company?
Recent Insider Trading
  • Alibaba Health Information Technology individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
23. Mar 20 Sell Qiang Wang Individual 18. Mar 20 18. Mar 20 -74,628 €1.41 €-105,529
16. Jul 19 Buy Ant Small And Micro Financial Services Group Co., Ltd, Asset Management Arm Company 12. Jul 19 12. Jul 19 60,576,000 €0.85 €51,582,048
16. Jul 19 Buy Alibaba Group Holding Limited Company 12. Jul 19 12. Jul 19 242,400,000 €0.85 €206,409,940
X
Management checks
We assess Alibaba Health Information Technology's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Alibaba Health Information Technology has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

TWY News

Simply Wall St News

TWY Company Info

Description

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People’s Republic of China. It engages in business-to-customer (B2C) retail activities; advertisement business; and business-to-business (B2B) centralized procurement distribution business. The company also provides pharmaceutical and healthcare products through its online stores on Tmall.com and offline pharmacy outlets to B2C and B2B customers; marketing services; health consultation services; outsourced and value-added services to the Tmall entities; and telemedicine services. In addition, it trades in pharmaceutical products; and offers network hospital services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. The company is based in Causeway Bay, Hong Kong.

Details
Name: Alibaba Health Information Technology Limited
TWY
Exchange: DB
Founded:
HK$18,274,055,820
12,062,521,094
Website: http://www.alihealth.cn
Address: Alibaba Health Information Technology Limited
Tower One,
26th Floor,
Causeway Bay,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 241 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 24. Aug 1998
OTCPK ALBH.F Ordinary Shares Pink Sheets LLC US USD 24. Aug 1998
DB TWY Ordinary Shares Deutsche Boerse AG DE EUR 24. Aug 1998
BST TWY Ordinary Shares Boerse-Stuttgart DE EUR 24. Aug 1998
SHSC 241 Ordinary Shares Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect HK HKD 24. Aug 1998
SZSC 241 Ordinary Shares The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect HK HKD 24. Aug 1998
OTCPK ALBB.Y UNSPONSORD ADR Pink Sheets LLC US USD 26. Jul 2017
Number of employees
Current staff
Staff numbers
884
Alibaba Health Information Technology employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 20:45
End of day share price update: 2020/03/31 00:00
Last estimates confirmation: 2020/03/26
Last earnings filing: 2019/12/18
Last earnings reported: 2019/09/30
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.